A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Clinical trial NCT01241591 · COMPLETED
Trial details
- NCT number
- NCT01241591
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 1101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.